Universal Health (UHS) Misses Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Universal Health Services (UHS) PT Raised to $227 at Cantor Fitzgerald
October 28, 2024 6:38 AM EDTCantor Fitzgerald analyst Sarah James raised the price target on Universal Health Services (NYSE: UHS) to $227.00 (from $219.00) while maintaining a Neutral rating.
The analyst comments "We are raising our 12-month price target to $227 from $219. Our 7.9x '26E EV/EBITDA reflects... More
Universal Health Services (UHS) PT Lowered to $211 at RBC Capital
October 28, 2024 6:31 AM EDTRBC Capital analyst Frank Morgan lowered the price target on Universal Health Services (NYSE: UHS) to $211.00 (from $222.00) while maintaining a Sector Perform rating.
The analyst comments "UHS stock traded off ~10% Friday on elevated buyside expectations with several investors pointing to softer... More
Deutsche Bank Reiterates Buy Rating on Universal Health Services (UHS)
October 28, 2024 5:56 AM EDTDeutsche Bank analyst Pito Chickering reiterated a Buy rating and $240.00 price target on Universal Health Services (NYSE: UHS)
The analyst comments "Net-net. While the election may be an overhang over the next couple of weeks, especially given Trumps position on exchange subsidies; ultimately, we dont believe UHS deserves to be down almost 10% today. The 3Q performance and lack of an increase to guidance wasnt enough to support the stock... More
